The London Alternative Investment Market, commonly known by its acronym AIM is a key market on the London Stock Exchange and gives investors the opportunity to invest in smaller, more dynamic, high-growth companies.
While a lot of focus in 2024 has been on American tech stocks, and the so-called best-performing FAANGs, there are a lot of successful and exciting British businesses listed on AIM that are delivering some exceptional returns to shareholders. In this article, we highlight six companies – Time Finance, Cerillion, Quadrise, Hercules Site Services, Poolbeg Pharma and SAE Renewables – who’s share prices have grown by between circa 50% and 150% over the last 12-months. They still remain on low valuations with lots of upside potential in their share prices given the relative position of the UK stock market and their strong investment cases. By contrast, the FTSE AIM All-Share Index has risen only 6.13% today over the same 12 month period.
Time Finance plc (LON:TIME) is an independent AIM listed finance company lending to small UK businesses through a variety of Asset Finance, Invoice Finance, Loans and Vehicle Finance. TIME’s share price has grown over 96% in 1 year to 52 GBX today.
Cerillion plc (LON:CER) is a leading provider of billing, charging and customer management systems with more than 20 years’ experience delivering its solutions across a broad range of industries including the telecommunications, finance, utilities and transportation sectors. Cerillion’s share price has grown c. 59% in 1 year to 1,915 GBX today.
Quadrise plc (LON:QED) produce transition fuels called MSAR® (pronounced ‘em-sar’) and bioMSAR™, which allow clients in the shipping, utilities and industrial sectors to reduce carbon emissions whilst also saving costs. Quadrise’s share price has grown over 72% in 1 year to 1.90 GBX today.
Hercules Site Services plc (LON:HERC) is a collaborative, innovative company delivering services of the highest standards within the Civil Engineering sector of the construction industry. Hercules’s share price has grown over 63% in 1 year to 47.45 GBX today.
Poolbeg Pharma plc (LON:POLB) is committed to the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, with a growing emphasis on rare and orphan diseases. Poolbeg’s share price has grown over 51% in 1 year to 12.4 GBX today.
SAE Renewables Limited (LON:SAE) aim is to be a global leader in the creation of new, sustainable energy projects for the benefit of our planet. SAE’s share price has grown over 149% in 1 year to 2.5 GBX today.